We are live on ! Find out more
WCM

Wedge Capital Management Portfolio holdings

AUM $6.06B
1-Year Est. Return 47.24%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+47.24%
3 Year Est. Return
+138.72%
5 Year Est. Return
+177.67%
10 Year Est. Return
+528.98%
AUM
$9.6B
AUM Growth
+$119M
Cap. Flow
-$9.04M
Cap. Flow %
-0.09%
Top 10 Hldgs %
15.95%
Holding
636
New
50
Increased
233
Reduced
252
Closed
65

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$75.1M
2
GILD icon
Gilead Sciences
GILD
+$39.7M
3
ABBV icon
AbbVie
ABBV
+$39.2M
4
LLTC
Linear Technology Corp
LLTC
+$34.8M
5
COL
Rockwell Collins
COL
+$34.7M

Top Sells

Rank Stock Value
1
DRE
Duke Realty Corp.
DRE
+$82.1M
2
JWN
Nordstrom
JWN
+$74.7M
3
BC icon
Brunswick
BC
+$49.5M
4
NWL icon
Newell Brands
NWL
+$43.7M
5
BA icon
Boeing
BA
+$40.8M

Sector Composition

Rank Sector Weight
1 Financials 20.1%
2 Consumer Discretionary 14.84%
3 Industrials 13.24%
4 Healthcare 11.11%
5 Technology 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THS
51
DELISTED
Treehouse Foods
THS
$50.8M 0.53%
585,858
+80,978
+16% +$6.47M
AMSG
52
DELISTED
Amsurg Corp
AMSG
$46.6M 0.49%
625,207
-2,285
-0.4% -$161K
ACM icon
53
Aecom
ACM
$9.22B
$44.8M 0.47%
1,453,494
-17,863
-1% -$496K
CSC
54
DELISTED
Computer Sciences
CSC
$43.7M 0.46%
1,270,316
+25,062
+2% +$756K
DFT
55
DELISTED
DuPont Fabros Technology Inc.
DFT
$43M 0.45%
1,061,599
-20,228
-2% -$703K
BSX icon
56
Boston Scientific
BSX
$68.4B
$42.7M 0.45%
2,270,799
+88,099
+4% +$1.55M
GD icon
57
General Dynamics
GD
$103B
$42.5M 0.44%
323,709
+1,644
+0.5% +$218K
SYK icon
58
Stryker
SYK
$133B
$42M 0.44%
391,270
-2,920
-0.7% -$288K
AMGN icon
59
Amgen
AMGN
$209B
$41.9M 0.44%
279,291
+30,416
+12% +$4.52M
PFE icon
60
Pfizer
PFE
$142B
$41.1M 0.43%
1,462,737
+228,371
+19% +$6.52M
UN
61
DELISTED
Unilever NV New York Registry Shares
UN
$41.1M 0.43%
918,778
+56,403
+7% +$2.43M
MRK icon
62
Merck
MRK
$321B
$40.7M 0.42%
805,264
+50,940
+7% +$2.49M
CAH icon
63
Cardinal Health
CAH
$53.2B
$40.6M 0.42%
495,842
+34,767
+8% +$2.83M
JNJ icon
64
Johnson & Johnson
JNJ
$617B
$40.5M 0.42%
374,141
-18,890
-5% -$1.96M
GILD icon
65
Gilead Sciences
GILD
$163B
$40.5M 0.42%
+440,475
New +$39.7M
ELV icon
66
Elevance Health
ELV
$81.6B
$40.3M 0.42%
289,840
+22,630
+8% +$3.02M
AET
67
DELISTED
Aetna Inc
AET
$40.2M 0.42%
358,070
+11,465
+3% +$1.23M
ABBV icon
68
AbbVie
ABBV
$455B
$40.1M 0.42%
+702,481
New +$39.2M
STAG icon
69
STAG Industrial
STAG
$7.43B
$40M 0.42%
1,964,047
-50,183
-2% -$887K
COR icon
70
Cencora
COR
$60.7B
$40M 0.42%
461,966
+83,666
+22% +$7.45M
AZN icon
71
AstraZeneca
AZN
$266B
$39.9M 0.42%
708,040
+115,490
+19% +$6.94M
KDP icon
72
Keurig Dr Pepper
KDP
$43B
$39.8M 0.41%
445,177
+11,332
+3% +$1.03M
ENS icon
73
EnerSys
ENS
$6.74B
$39.4M 0.41%
707,283
-9,168
-1% -$473K
ESRX
74
DELISTED
Express Scripts Holding Company
ESRX
$39M 0.41%
567,944
+112,519
+25% +$8.09M
ACN icon
75
Accenture
ACN
$99.9B
$38.8M 0.4%
336,053
-55,472
-14% -$5.7M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Wedge Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Wedge Capital Management held 636 positions worth $9.6B, up 1.3% from $9.48B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wedge Capital Management's Q1 2016 filing shows 50 new, 233 increased, 252 reduced and 65 closed positions. Its largest new stake was Gilead Sciences: 440,475 shares worth $40.5M. The largest sale was Duke Realty Corp., an estimated $82.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Wedge Capital Management's largest Q1 2016 buy was Gilead Sciences: 440,475 shares worth $40.5M.
  • Wedge Capital Management added most to Cullen/Frost Bankers in Q1 2016, an estimated $75.1M increase.
  • Wedge Capital Management's biggest Q1 2016 reduction was Brunswick, cutting an estimated $49.5M.
  • Wedge Capital Management fully exited Duke Realty Corp. in Q1 2016, selling an estimated $82.1M.
  • Wedge Capital Management's ten largest holdings make up 16% of its $9.6B portfolio in Q1 2016.
  • Wedge Capital Management opened 50 new positions and closed 65 in Q1 2016.
  • Wedge Capital Management's portfolio value rose 1.3% quarter-over-quarter to $9.6B.

Based on Wedge Capital Management's 13F filing for Q1 2016, filed 2 May 2016.